Phillip J. Young - Strategic Advisor

Phil is an experienced life sciences executive who has successfully managed public and private companies through product development, growth and commercialization or divestiture. He has served as a Director and Executive Officer for companies for the past 20 years where has had created significant shareholder value, built integrated scientific and commercial operations, directed successful M&A transactions and was responsible for generating more the $900M through acquisitions and equity financings.  He has extensive relationships and has managed transactions in Europe, Japan and Oceania.

 

Phil was most recently the President and Chief Executive Officer and Director for AmpliPhi Biosciences from, a global biopharmaceutical company where he completed a transformational restructuring, inked collaborations and financings.  He is the former President, CEO and Director of Osteologix, Inc. having established corporate offices in Ireland after successfully completing a global divestiture of its lead program.  Prior to joining Osteologix, Phil served as an Executive Vice President and Chief Business Officer for Insmed Inc., a publicly traded biotechnology company where he directed all financing, commercial and corporate communications activities. Prior to Insmed Inc., Phil held executive positions at Elan, Neurex and Pharmacia Corporations.

 

Phil started his management career in the biopharmaceutical industry at Genentech Inc. where he was responsible for their cardiovascular and endocrine product launches sales and marketing.